Literature DB >> 25196665

Bone marrow necrosis discovered in a patient with suspected thrombotic thrombocytopenic purpura.

Hiral D Parekh1, Jessica A Reese, Patrick W Cobb, James N George.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25196665      PMCID： PMC4333067          DOI： 10.1002/ajh.23840

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  21 in total

Review 1.  Bone marrow necrosis.

Authors:  A M Janssens; F C Offner; W Z Van Hove
Journal:  Cancer       Date:  2000-04-15       Impact factor: 6.860

2.  Multiorgan failure and bone marrow necrosis in three adults with sickle cell-β+ -thalassemia.

Authors:  Jill Adamski; Courtney A Hanna; Vishnu B Reddy; Silvio H Litovsky; Cristina A Evans; Marisa B Marques
Journal:  Am J Hematol       Date:  2012-02-28       Impact factor: 10.047

3.  Diagnostic and prognostic values of ADAMTS13 activity measured during daily plasma exchange therapy in patients with acquired thrombotic thrombocytopenic purpura.

Authors:  Nan Wu; Jia Liu; Shangbin Yang; Eric T Kellett; Spero R Cataland; Hong Li; Haifeng M Wu
Journal:  Transfusion       Date:  2014-06-23       Impact factor: 3.157

4.  First symptoms in patients with thrombotic thrombocytopenic purpura: what are they and when do they occur?

Authors:  Drees Griffin; Zayd L Al-Nouri; Darrshini Muthurajah; John R Ross; Riley B Ballard; Deirdra R Terrell; Sara K Vesely; James N George; Marisa B Marques
Journal:  Transfusion       Date:  2013-01       Impact factor: 3.157

5.  Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).

Authors:  Neil Shah; Cynthia Rutherford; Karen Matevosyan; Yu-Min Shen; Ravi Sarode
Journal:  Br J Haematol       Date:  2013-09-20       Impact factor: 6.998

Review 6.  Syndromes of thrombotic microangiopathy.

Authors:  James N George; Carla M Nester
Journal:  N Engl J Med       Date:  2014-08-14       Impact factor: 91.245

7.  Bone marrow necrosis in de novo AML.

Authors:  Michael Daskalakis; Marcelo Caballero
Journal:  Blood       Date:  2014-04-03       Impact factor: 22.113

8.  Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura.

Authors:  Cassandra C Deford; Jessica A Reese; Lauren H Schwartz; Jedidiah J Perdue; Johanna A Kremer Hovinga; Bernhard Lämmle; Deirdra R Terrell; Sara K Vesely; James N George
Journal:  Blood       Date:  2013-07-09       Impact factor: 22.113

9.  Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency.

Authors:  James N George; Qiaofang Chen; Cassie C Deford; Zayd Al-Nouri
Journal:  J Clin Apher       Date:  2012-08-28       Impact factor: 2.821

Review 10.  Evaluation of patients with microangiopathic hemolytic anemia and thrombocytopenia.

Authors:  James N George; Roseleen S Charania
Journal:  Semin Thromb Hemost       Date:  2013-02-06       Impact factor: 4.180
View more
  1 in total

Review 1.  The standard of care for immune thrombotic thrombocytopenic purpura today.

Authors:  X Long Zheng
Journal:  J Thromb Haemost       Date:  2021-06-30       Impact factor: 16.036
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.